DONG LU to Nuclear Receptor Coactivator 3
This is a "connection" page, showing publications DONG LU has written about Nuclear Receptor Coactivator 3.
Connection Strength
0.242
-
Lead Compound Development of SRC-3 Inhibitors with Improved Pharmacokinetic Properties and Anticancer Efficacy. J Med Chem. 2024 Apr 11; 67(7):5333-5350.
Score: 0.200
-
Development of improved SRC-3 inhibitors as breast cancer therapeutic agents. Endocr Relat Cancer. 2021 08 13; 28(10):657-670.
Score: 0.042